뉴스벤징가
HUTCHMED's Experimental Drug Shows Durable Responses In Advanced Bile Duct Cancer Trial
· 발표
기사 요약
HUTCHMED reported positive Phase 2 data for fanregratinib in advanced ICC as China reviews the drug.
기사 원문에서 발췌했어요.HUTCHMED reported positive Phase 2 data for fanregratinib in advanced ICC as China reviews the drug.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…